Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 24 of 24 publications.

Singer D, La E, Graham J, Grace M, Poston S, Molnar D. Cost effectiveness of adjuvanted RSVPreF3 vaccination in adults aged 50-59 years with diabetes in the United States. Poster presented at the American Diabetes Association's 84th Scientific Sessions; June 21, 2024. Orlando, FL. [abstract] Diabetes. 2024 Jun; 73(Suppl 1):1045.

Gaudiani L, Sikirica S, Hardin MB, Ervin CM, Goss DS, Kosa KM, Gopinathan S. Patient-reported burden of disease in diabetic peripheral neuropathic pain: learnings from in-depth patient interviews, sub-study of RELIEF-DPN 1. Poster presented at the American Diabetes Association's 84th Scientific Sessions; June 21, 2024. Orlando, FL. [abstract] Diabetes. 2024 Jun; 73(Suppl 1):484.

Schapiro D, Perez-Nieves M, Vass CM, Ling Poon J, Gelsey FT, Pierce A, Mansfield C. Preferences of people with type 1 diabetes for features of weekly insulin. Poster presented at the American Diabetes Association's 84th Scientific Sessions; June 21, 2024. Orlando, FL. [abstract] Diabetes. 2024 Jun; 73(Suppl 1):831. doi: 10.2337/db24-831-P

Gelsey F, Perez-Nieves M, Vass CM, Ling Poon J, Schapiro D, Pierce A, Mansfield C. Preferences of people with type 2 diabetes for features of weekly insulin. Poster presented at the American Diabetes Association's 84th Scientific Sessions; June 21, 2024. Orlando, FL. [abstract] Diabetes. 2024 Jun; 73(Suppl 1):832. doi: 10.2337/db24-832-P

La EM, Bunniran S, Garbinsky D, Reynolds M, Poston S, Harrington L. Knowledge, attitudes, and perceptions of respiratory syncytial virus (RSV) among U.S. adults with diabetes. Poster presented at the ADA 2023 Conference; June 24, 2023. San Diego, CA. [abstract] Diabetes. 2023 Jun 20; 72(Suppl 1). doi: 10.2337/db23-524-P

Anthony MS, Djebarri L, Beachler DC, Aroda VR, Calingaert B, Pan C, Crowe C, Lanes S, Rothman KJ, Saltus CW, Berreghis S, Parlett LE, Bocage C, Walsh KE, Juhaeri J, Johannes C. Risk of anaphylaxis among new users of glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Poster presented at the American Diabetes Association's 83rd Scientific Sessions; June 23, 2023. San Diego, CA. [abstract] Diabetes. 2023 Jun 20; 72(supplement_1):846-P. doi: 10.2337/db23-846-P

Fernandez MM, Mordin M, Hadacek MB, Moecklinghoff C, Vloeberghs E, El khoury A, Tronczynski K. PrEP reimbursement and access in Europe: 2019 update. Poster presented at the 17th European AIDS Conference; November 2019. Basel, Switzerland. [abstract] HIV Med. 2019 Nov 6; 20(Suppl. 9):240. doi: 10.1111/hiv.12814

Brogan AJ, Talbird SE, Davis AE, Wild L, Flanagan D. Is increased screening and early antiretroviral treatment for HIV-1 worth the investment? An analysis of the public health and economic impact of improvement in the UK. HIV Med. 2019 Nov;20(10):668-80. doi: 10.1111/hiv.12788

Wilkins E, Fisher M, Brogan AJ, Talbird SE, La EM. Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical trial. HIV Med. 2016 Aug;17(7):505-15. doi: 10.1111/hiv.12349

Morelli X, Foraster M, Aguilera I, Basagana X, Corradi E, Deltell A, Ducret-Stich R, Phuleria H, Ragettli MS, Rivera M, Thomasson A, Kunzli N, Slama R. Short-term associations between traffic-related noise, particle number and traffic flow in three European citie. Atmos Environ. 2015 Feb;103:25-33. doi: 10.1016/j.atmosenv.2014.12.012

Ragettli MS, Ducret-Stich RE, Foraster M, Morelli X, Aguilera I, Basagana X, Corradi E, Ineichen A, Tsai M, Probst-Hensch N, Rivera M, Slama R, Kunzli N, Phuleria HC. Spatio-temporal variation of urban ultrafine particle number concentrations. Atmos Environ. 2014 Oct;96:275-83. doi: 10.1016/j.atmosenv.2014.07.049

Kosa KM, Cates SC, Hall AJ, Brophy JE, Frasier A. Knowledge of norovirus prevention and control among infection preventionists. Poster presented at the 2014 APIC’s 41st Annual Conference; June 2014. Anaheim, CA. [abstract] Am J Infect Control. 2014 Jun; 42(6):676-8. doi: 10.1016/j.ajic.2014.02.004

Aguilera I, Basagana X, Pay MT, Agis D, Bouso L, Foraster M, Rivera M, Baldasano JM, Kunzli N. Evaluation of the CALIOPE air quality forecasting system for epidemiological research: the example of NO2 in the province of Girona (Spain). Atmos Environ. 2013 Jun;72:134-41. doi: 10.1016/j.atmosenv.2013.02.035

Rivera M, Basagana X, Aguilera I, Agis D, Bouso L, Foraster M, Medina-Ramon M, Pey J, Kunzli N, Hoek G. Spatial distribution of ultrafine particles in urban settings: a land use regression model. Atmos Environ. 2012 Jul;54:657-66. doi: 10.1016/j.atmosenv.2012.01.058

Basagana X, Rivera M, Aguilera I, Agis D, Bouso L, Elosua R, Foraster M, de Nazelle A, Nieuwenhuijsen M, Vila J, Kunzli N. Effect of the number of measurement sites on land use regression models in estimating local air pollution. Atmos Environ. 2012 Jul;54:634-42. doi: 10.1016/j.atmosenv.2012.01.064

Mladsi D, Curtis S, Bell MJ, Ito T, Wilson M, Aboud M. Resource utilisation and cost of managing adverse events (AEs) associated with highly active antiretroviral therapy (HAART) in patients with HIV-1. Poster presented at the 18th Annual Conference of the British HIV Association; April 1, 2012. Birmingham, UK. [abstract] HIV Med. 2012 Apr 18; 13(SI):17-8.

Menzin J, Meyers JL, Friedman M, Korn JR, Perfect JR, Langston AA, Danna RP, Papadopoulos G. The economic costs to United States hospitals of invasive fungal infections in transplant patients. Am J Infect Control. 2011 May 1;39(4):e15-20.

Menzin J, Marton JP, Meyers JL, Carson RT, Rothermel CD, Friedman M. Inpatient treatment patterns, outcomes, and costs of skin and skin structure infections because of Staphylococcus aureus. Am J Infect Control. 2010 Feb;38(1):44-9. doi: 10.1016/j.ajic.2009.04.287.

Nichols GA, Gandra SR, Chiou CF, Anthony MS, Alexander-Bridges M, Brown JB. Glycemic control and adverse events after insulin initiation in clinical practice. Poster presented at the 68th Scientific Sessions of the American Diabetes Association; 2008. [abstract] Diabetes. 2008; 57 (Suppl 1).

Greene BL, Brown TM, Harshman RS, Richerson GT, Turner BH, Skrepnek SH, Doyle JJ. Impact of the BP DownShift Program on blood pressure control among commercial driver license employees with diabetes and obesity. Poster presented at the 67th Scientific Sessions of the American Diabetes Association; June 2007. [abstract] Diabetes. 2007 Jun; 56(Suppl 1):A500.

Philip S, Fleming A, Goatman K, Sharp P, Olson J. Automated image quality assessment is an essential step for automating diabetic retinopathy detection. Poster presented at the 66th Scientific Session; June 9, 2006. Washington, DC. [abstract] Diabetes. 2006 Jun 9; 55(supplement 1):A513.

Richter A, Pladevall M, Manjunath R, Lafata JE, Xi H, Simpkins J, Brar I, Markowitz N, Iloeje U, Irish W. Patient characteristics and costs associated with dyslipidaemia and related conditions in HIV-infected patients: a retrospective cohort study. HIV Med. 2005 Mar 1;6(2):79-90.

Flavell DM, Ireland H, Stephens JW, Hawe E, Acharya J, Mather H, Hurel SJ, Humphries SE. Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes. Diabetes. 2005;54(2):582-6.

Wagner JD, Welles EG, Bell-Farrow AD, Anthony MS, Cefalu WT. Non-ketotic hyperglycemia and obesity preceding insulinopenic state in aged monkeys (macaca fascicularis). Diabetes. 1991;40(Suppl 40):219A.